PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 22 PubMed articles · model: gemma4:31b
Summary
Passiflora species, including maypop, are used to relieve mild neurological disorders such as anxiety, depression, and stress [PMID:36144755].
Background
Passiflora (passion vine) is a genus of plants characterized by a diverse range of defense compounds, including cyanogenic glucosides [PMID:28901723].
Traditional uses
Plants derived from the Passiflora genus (such as maypop) are commonly used to treat symptoms of depression, anxiety, and stress [PMID:36144755].
Active compounds
Passiflora plants contain an extensive diversity of defense compounds known as cyanogenic glucosides [PMID:28901723, PMID:31110663].
Clinical evidence
Evidence BMild neurological disorders (depression, anxiety, and stress)
Clinical trials have consistently shown that maypop (Passiflora) can relieve mild forms of these disorders [PMID:36144755].
Evidence summary
The evidence for the use of Passiflora in treating mild anxiety and depression is based on clinical trials, though the provided data is limited to a review of multiple herbal products.
PubMed sources
- 1.PMID: 36144755 (2022) — Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update. · Molecules (Basel, Switzerland)
- 2.PMID: 28901723 (2018) — The arms race between heliconiine butterflies and Passiflora plants - new insights on an ancient subject. · Biological reviews of the Cambridge Philosophical Society
- 3.PMID: 31110663 (2019) — Sequestration and biosynthesis of cyanogenic glucosides in passion vine butterflies and consequences for the diversification of their host plants. · Ecology and evolution